Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Melanoma”

448 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 448 results

Not applicableUnknownNCT04107168
What this trial is testing

Microbiome Immunotherapy Toxicity and Response Evaluation

Who this might be right for
MelanomaRenal CancerLung Cancer
CCTU- Cancer Theme 1,800
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Testing effectiveness (Phase 2)Ended earlyNCT03009058
What this trial is testing

Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

Who this might be right for
Metastatic Cancer
Immodulon Therapeutics Ltd 2
Early research (Phase 1)Ended earlyNCT01611675
What this trial is testing

Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma

Who this might be right for
Melanoma
Massachusetts General Hospital 3
Early research (Phase 1)Ended earlyNCT03712358
What this trial is testing

PVSRIPO for Patients With Unresectable Melanoma

Who this might be right for
Melanoma
Istari Oncology, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00121225
What this trial is testing

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT04526899
What this trial is testing

Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVUnresectable Melanoma
BioNTech SE 184
Large-scale testing (Phase 3)Active Not RecruitingNCT06320353
What this trial is testing

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

Who this might be right for
Skin Melanoma
R-Pharm 266
Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)Study completedNCT04493203
What this trial is testing

Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma

Who this might be right for
Advanced MelanomaUnresectable Melanoma
Yana Najjar 31
Large-scale testing (Phase 3)Study completedNCT02908672
What this trial is testing

Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Who this might be right for
Melanoma
Hoffmann-La Roche 514
Large-scale testing (Phase 3)Study completedNCT00111007
What this trial is testing

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Bayer 270
Testing effectiveness (Phase 2)WithdrawnNCT05572463
What this trial is testing

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Who this might be right for
Unresectable Cutaneous MelanomaMetastatic Cutaneous Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Not applicableStudy completedNCT04911998
What this trial is testing

A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

Who this might be right for
Melanoma (Skin)Metastatic MelanomaBRAF V600 Mutation
Pierre Fabre Medicament 400
Testing effectiveness (Phase 2)Study completedNCT00338130
What this trial is testing

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Who this might be right for
Melanoma
AstraZeneca 239
Early research (Phase 1)Looking for participantsNCT06377111
What this trial is testing

Test the Benefit of Vitamin B5 in Patients With Melanoma

Who this might be right for
Melanoma (Skin)
University Health Network, Toronto 12
Testing effectiveness (Phase 2)Looking for participantsNCT05428007
What this trial is testing

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
MelanomaUnresectable Melanoma
NYU Langone Health 105
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT07280832
What this trial is testing

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

Who this might be right for
Unresectable Locally Advanced or Metastatic Melanoma
Shanghai JMT-Bio Inc. 188
Testing effectiveness (Phase 2)Study completedNCT00185302
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Who this might be right for
Melanoma
Bayer 28
Load More Results